Product Name

  • Name

    Abacavir

  • EINECS 620-487-9
  • CAS No. 136470-78-5
  • Article Data23
  • CAS DataBase
  • Density 1.7 g/cm3
  • Solubility
  • Melting Point 165°
  • Formula C14H18N6O
  • Boiling Point 636 °C at 760 mmHg
  • Molecular Weight 286.337
  • Flash Point 338.4 °C
  • Transport Information
  • Appearance white powder
  • Safety
  • Risk Codes R21; R23/25; R43; R50/53
  • Molecular Structure Molecular Structure of 136470-78-5 (Abacavir)
  • Hazard Symbols T,N
  • Synonyms {(1S,4R)-4-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]cyclopent-2-en-1-yl}methanol;Ziagen;2-Cyclopentene-1-methanol, 4-(2-amino-6-(cyclopropylamino)-9H-purin-9-yl)-, (1S-cis)-;4-Amino-5-chloro-2-ethoxy benzoic acid;Trizivir;2-Cyclopentene-1-methanol, 4-(2-amino-6-(cyclopropylamino)-9H-purin-9-yl)-, (1S,4R)-;Abacavir (Ziagen);
  • PSA 101.88000
  • LogP 1.74650

Synthetic route

(1S,4R)-4-[2-amino-6-chloro-9H-purin-9-yl]-2-cyclopentene-1-methanol
136522-33-3

(1S,4R)-4-[2-amino-6-chloro-9H-purin-9-yl]-2-cyclopentene-1-methanol

Cyclopropylamine
765-30-0

Cyclopropylamine

abacavir
136470-78-5

abacavir

Conditions
ConditionsYield
In ethanol at 70℃;98%
In ethanol Heating;72%
Stage #1: (1S,4R)-4-[2-amino-6-chloro-9H-purin-9-yl]-2-cyclopentene-1-methanol; Cyclopropylamine In butan-1-ol at 40 - 70℃; for 5h;
Stage #2: With sodium hydrogencarbonate In butan-1-ol at 20 - 25℃; for 1h; Product distribution / selectivity;
In butan-1-ol at 45 - 90℃; for 2h; Product distribution / selectivity;
With sodium hydrogencarbonate In ethanol; chloroform0.43 g (80%)
Cyclopropylamine
765-30-0

Cyclopropylamine

(1S,cis)-4-(2-amino-6-chloro-9-H-purin-9-yl)-2-cyclopentene-1-methanol hydrochloride
172015-79-1

(1S,cis)-4-(2-amino-6-chloro-9-H-purin-9-yl)-2-cyclopentene-1-methanol hydrochloride

abacavir
136470-78-5

abacavir

Conditions
ConditionsYield
In methanol at 70℃; for 12h; Substitution;90%
Stage #1: (1S,cis)-4-(2-amino-6-chloro-9-H-purin-9-yl)-2-cyclopentene-1-methanol hydrochloride With triethylamine In water
Stage #2: Cyclopropylamine In water at 70 - 75℃; Concentration; Solvent; Temperature;
90%
In isopropyl alcohol at 90 - 95℃; for 12h; sealed reactor;
In ethanol at 25 - 78℃; for 6h;
With sodium carbonate In ethanol at 70 - 80℃;25 g
(-)-N-{6-(cyclopropylamino)-9-[(1R,4S)-4-(hydroxymethyl)cyclopent-2-enyl]-9H-purin-2-yl}isobutyramide
136470-88-7

(-)-N-{6-(cyclopropylamino)-9-[(1R,4S)-4-(hydroxymethyl)cyclopent-2-enyl]-9H-purin-2-yl}isobutyramide

abacavir
136470-78-5

abacavir

Conditions
ConditionsYield
Stage #1: (-)-N-{6-(cyclopropylamino)-9-[(1R,4S)-4-(hydroxymethyl)cyclopent-2-enyl]-9H-purin-2-yl}isobutyramide With isopropyl alcohol; sodium hydroxide for 1h; Reflux;
Stage #2: With hydrogenchloride In water; isopropyl alcohol at 20 - 25℃; pH=7.0 - 7.5; Product distribution / selectivity;
90%
With sodium hydroxide; water; isopropyl alcohol for 1h; Heating / reflux;77%
With sodium hydroxide; water; isopropyl alcohol for 1h; Product distribution / selectivity; Heating / reflux;43%
pyrographite
7440-44-0

pyrographite

Cyclopropylamine
765-30-0

Cyclopropylamine

(1S,cis)-4-(2-amino-6-chloro-9-H-purin-9-yl)-2-cyclopentene-1-methanol hydrochloride
172015-79-1

(1S,cis)-4-(2-amino-6-chloro-9-H-purin-9-yl)-2-cyclopentene-1-methanol hydrochloride

abacavir
136470-78-5

abacavir

Conditions
ConditionsYield
With sodium hydroxide In acetone90%
6-cyclopropylamine-9-((1R,4S)-4-((triisopropylsilyloxy)methyl)cyclopent-2-enyl)-9H-purin-2-amine
1067882-78-3

6-cyclopropylamine-9-((1R,4S)-4-((triisopropylsilyloxy)methyl)cyclopent-2-enyl)-9H-purin-2-amine

abacavir
136470-78-5

abacavir

Conditions
ConditionsYield
With tetrabutyl ammonium fluoride; water In tetrahydrofuran at 20℃; for 1h; Inert atmosphere;89%
{(1S,4R)-4-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]cyclopent-2-en-1-yl}methanol sulphate

{(1S,4R)-4-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]cyclopent-2-en-1-yl}methanol sulphate

abacavir
136470-78-5

abacavir

Conditions
ConditionsYield
With sodium hydroxide In water; ethyl acetate at 25 - 45℃; pH=6 - 6.1;78%
((1S,4R)-4-(6-(cyclopropylamino)-2-((4-methoxybenzyl)amino)-9H-purin-9-yl)cyclopent-2-en-1-yl)methanol
1360538-03-9

((1S,4R)-4-(6-(cyclopropylamino)-2-((4-methoxybenzyl)amino)-9H-purin-9-yl)cyclopent-2-en-1-yl)methanol

abacavir
136470-78-5

abacavir

Conditions
ConditionsYield
With trifluoroacetic acid In chloroform at 50℃; for 72h; Inert atmosphere;73%
N6-cyclopropyl-N2-(4-methoxybenzyl)-9-((1R,4S)-4-(((triisopropylsilyl)oxy)methyl)cyclopent-2-en-1-yl)-9H-purine-2,6-diamine

N6-cyclopropyl-N2-(4-methoxybenzyl)-9-((1R,4S)-4-(((triisopropylsilyl)oxy)methyl)cyclopent-2-en-1-yl)-9H-purine-2,6-diamine

abacavir
136470-78-5

abacavir

Conditions
ConditionsYield
With trifluoroacetic acid In dichloromethane at 60℃; for 60h; Schlenk technique;70%
((1S,4R)-4-(2-chloro-6-(cyclopropylamino)-9H-purin-9-yl)cyclopent-2-en-1-yl)methanol
1108600-46-9

((1S,4R)-4-(2-chloro-6-(cyclopropylamino)-9H-purin-9-yl)cyclopent-2-en-1-yl)methanol

abacavir
136470-78-5

abacavir

Conditions
ConditionsYield
With ammonium hydroxide; copper(l) iodide In ethanol at 150℃; for 40h; Schlenk technique; Sealed tube;63%
Stage #1: ((1S,4R)-4-(2-chloro-6-(cyclopropylamino)-9H-purin-9-yl)cyclopent-2-en-1-yl)methanol With hydrazine In methanol; water at 50℃;
Stage #2: With acetic acid; sodium nitrite In water at 0℃; for 1h;
Stage #3: With tin(ll) chloride In ethanol for 2h; Product distribution / selectivity; Heating / reflux;
Stage #1: ((1S,4R)-4-(2-chloro-6-(cyclopropylamino)-9H-purin-9-yl)cyclopent-2-en-1-yl)methanol With hydrazine In methanol at 50℃;
Stage #2: With acetic acid; sodium nitrite In water at 0℃; for 1h;
Stage #3: With ammonia; triphenylphosphine In 1,4-dioxane; water for 5h; Product distribution / selectivity; Heating / reflux;
Multi-step reaction with 2 steps
1: dimethyl sulfoxide / 150 °C
2: trifluoroacetic acid / chloroform / 72 h / 50 °C / Inert atmosphere
View Scheme
Multi-step reaction with 3 steps
1: hydrazine hydrate / methanol / 50 °C
2: acetic acid; sodium nitrite / water / 1 h / Cooling with ice
3: stannous chloride dihydrate / ethanol / 2 h / Reflux
View Scheme
Cyclopropylamine
765-30-0

Cyclopropylamine

(1R,4S)-1-[(2-amino-6-chloro-5-formamido-4-pyrimidinyl)amino]-4-(hydroxymethyl)-2-cyclopentene
171887-04-0

(1R,4S)-1-[(2-amino-6-chloro-5-formamido-4-pyrimidinyl)amino]-4-(hydroxymethyl)-2-cyclopentene

A

(1S, 4R)-(4-(2,5-diamino-6-chloro-4-pyrimidinyl)amino)-2-cyclopenten-1-methanol
141271-12-7

(1S, 4R)-(4-(2,5-diamino-6-chloro-4-pyrimidinyl)amino)-2-cyclopenten-1-methanol

B

abacavir
136470-78-5

abacavir

Conditions
ConditionsYield
In butan-1-ol at 130℃; for 21h; Substitution; hydrolysis;A 16%
B 60%
2-Amino-6-chloropurin
10310-21-1

2-Amino-6-chloropurin

Cyclopropylamine
765-30-0

Cyclopropylamine

cis-3-benzoyloxy-4-(hydroxymethyl)cyclopentene
268737-86-6

cis-3-benzoyloxy-4-(hydroxymethyl)cyclopentene

abacavir
136470-78-5

abacavir

Conditions
ConditionsYield
Stage #1: 2-Amino-6-chloropurin; cis-3-benzoyloxy-4-(hydroxymethyl)cyclopentene With 1,2,2,6,6-pentamethylpiperidine; tris(dibenzylideneacetone)dipalladium (0); triphenylphosphine In tetrahydrofuran; dimethyl sulfoxide at 45℃; for 16h; Solid phase reaction; addition; elimination;
Stage #2: Cyclopropylamine With N-ethyl-N,N-diisopropylamine In butan-1-ol at 80℃; for 4h; Solid phase reaction; amination; Further stages.;
60%
(+/-)-cis-N-[4-chloro-5-formamido-6-[[4-(hydroxymethyl)-2-cyclopentene-1-yl]amino]-2-pyrimidinyl]acetamide

(+/-)-cis-N-[4-chloro-5-formamido-6-[[4-(hydroxymethyl)-2-cyclopentene-1-yl]amino]-2-pyrimidinyl]acetamide

ethanesulfonic acid
594-45-6

ethanesulfonic acid

orthoformic acid triethyl ester
122-51-0

orthoformic acid triethyl ester

Cyclopropylamine
765-30-0

Cyclopropylamine

abacavir
136470-78-5

abacavir

Conditions
ConditionsYield
In hydrogenchloride; methanol; N,N-dimethyl-formamide19%
((1S,4R)-4-(2-amino-6-(cyclopropylamino)-9H-purin-9-yl)cyclopent-2-en-1-yl)methyl acetate
178456-36-5

((1S,4R)-4-(2-amino-6-(cyclopropylamino)-9H-purin-9-yl)cyclopent-2-en-1-yl)methyl acetate

abacavir
136470-78-5

abacavir

Conditions
ConditionsYield
With sodium hydroxide; water Yield given;
With sodium hydroxide at 20℃;0.027 g
With sodium hydroxide
(1R,5R)-5-hydroxymethyl-2-cyclopenten-1-ol
143395-28-2

(1R,5R)-5-hydroxymethyl-2-cyclopenten-1-ol

abacavir
136470-78-5

abacavir

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: 90 percent / Et3N; DMAP / CH2Cl2 / 0 °C
2: 62 percent / NaH; Pd(PPh3)4 / dimethylsulfoxide; tetrahydrofuran / 45 °C
3: aq. NaOH
View Scheme
Multi-step reaction with 4 steps
1: 90 percent / Et3N; DMAP / CH2Cl2 / 0 °C
2: 0.298 g / NaH; Pd(PPh3)4 / dimethylsulfoxide; tetrahydrofuran / 45 °C
3: ethanol / 5 h / Heating
4: aq. NaOH
View Scheme
Multi-step reaction with 4 steps
1.1: Et3N
2.1: Et3N; 4-DMAP
3.1: aq. HF / acetonitrile
4.1: Pd2(dba)3; PPh3; 1,2,2,6,6-pentamethylpiperidine (pempidine) / tetrahydrofuran; dimethylsulfoxide / 16 h / 45 °C
4.2: 60 percent / EtN(i-Pr)2 / butan-1-ol / 4 h / 80 °C
View Scheme
2-amino-6-(cyclopropylamino)purine
120503-69-7

2-amino-6-(cyclopropylamino)purine

abacavir
136470-78-5

abacavir

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 62 percent / NaH; Pd(PPh3)4 / dimethylsulfoxide; tetrahydrofuran / 45 °C
2: aq. NaOH
View Scheme
2-Amino-6-chloropurin
10310-21-1

2-Amino-6-chloropurin

abacavir
136470-78-5

abacavir

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: dimethylsulfoxide / 16 h / 55 °C
2: 62 percent / NaH; Pd(PPh3)4 / dimethylsulfoxide; tetrahydrofuran / 45 °C
3: aq. NaOH
View Scheme
9-[cis-(1'R,4'S)-4'-acetoxymethyl-2'-cyclopenten-1'-yl]-9H-2-amino-6-chloropurine
162992-44-1

9-[cis-(1'R,4'S)-4'-acetoxymethyl-2'-cyclopenten-1'-yl]-9H-2-amino-6-chloropurine

abacavir
136470-78-5

abacavir

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: ethanol / 5 h / Heating
2: aq. NaOH
View Scheme
Multi-step reaction with 2 steps
1: ethanol
2: NaOH, H2O
View Scheme
(1R,2R)-2-acetoxy-1-(acetoxymethyl)-3-cyclopentene
178456-34-3

(1R,2R)-2-acetoxy-1-(acetoxymethyl)-3-cyclopentene

abacavir
136470-78-5

abacavir

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 62 percent / NaH; Pd(PPh3)4 / dimethylsulfoxide; tetrahydrofuran / 45 °C
2: aq. NaOH
View Scheme
Multi-step reaction with 3 steps
1: 0.298 g / NaH; Pd(PPh3)4 / dimethylsulfoxide; tetrahydrofuran / 45 °C
2: ethanol / 5 h / Heating
3: aq. NaOH
View Scheme
Multi-step reaction with 2 steps
1: 62 percent / NaH, Pd(PPh3)4 / tetrahydrofuran; dimethylsulfoxide
2: NaOH, H2O
View Scheme
Multi-step reaction with 3 steps
1: 65 percent / NaH, Pd(PPh3)4 / tetrahydrofuran; dimethylsulfoxide
2: ethanol
3: NaOH, H2O
View Scheme
[3(1R,2R),4S]-4-benzyl-3-(2-hydroxycyclopent-3-enecarbonyl)oxazolidin-2-one
178327-18-9

[3(1R,2R),4S]-4-benzyl-3-(2-hydroxycyclopent-3-enecarbonyl)oxazolidin-2-one

abacavir
136470-78-5

abacavir

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: 78 percent / LiBH4 / tetrahydrofuran; methanol / 1 h / 0 °C
2: 90 percent / Et3N; DMAP / CH2Cl2 / 0 °C
3: 62 percent / NaH; Pd(PPh3)4 / dimethylsulfoxide; tetrahydrofuran / 45 °C
4: aq. NaOH
View Scheme
Multi-step reaction with 5 steps
1: 78 percent / LiBH4 / tetrahydrofuran; methanol / 1 h / 0 °C
2: 90 percent / Et3N; DMAP / CH2Cl2 / 0 °C
3: 0.298 g / NaH; Pd(PPh3)4 / dimethylsulfoxide; tetrahydrofuran / 45 °C
4: ethanol / 5 h / Heating
5: aq. NaOH
View Scheme
Multi-step reaction with 4 steps
1: 78 percent / LiBH4 / tetrahydrofuran; methanol
2: 90 percent / Et3N, DMAP / CH2Cl2
3: 62 percent / NaH, Pd(PPh3)4 / tetrahydrofuran; dimethylsulfoxide
4: NaOH, H2O
View Scheme
Multi-step reaction with 5 steps
1: 78 percent / LiBH4 / tetrahydrofuran; methanol
2: 90 percent / Et3N, DMAP / CH2Cl2
3: 65 percent / NaH, Pd(PPh3)4 / tetrahydrofuran; dimethylsulfoxide
4: ethanol
5: NaOH, H2O
View Scheme
[3(2S,4R),4S]-3-(2-allyl-3-hydroxypent-4-enoyl)-4-benzyloxazolidin-2-one
178327-17-8

[3(2S,4R),4S]-3-(2-allyl-3-hydroxypent-4-enoyl)-4-benzyloxazolidin-2-one

abacavir
136470-78-5

abacavir

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1: 97 percent / (Cy3P)2Cl2Ru=CHPh / CH2Cl2 / 0.5 h / 25 °C
2: 78 percent / LiBH4 / tetrahydrofuran; methanol / 1 h / 0 °C
3: 90 percent / Et3N; DMAP / CH2Cl2 / 0 °C
4: 62 percent / NaH; Pd(PPh3)4 / dimethylsulfoxide; tetrahydrofuran / 45 °C
5: aq. NaOH
View Scheme
Multi-step reaction with 6 steps
1: 97 percent / (Cy3P)2Cl2Ru=CHPh / CH2Cl2 / 0.5 h / 25 °C
2: 78 percent / LiBH4 / tetrahydrofuran; methanol / 1 h / 0 °C
3: 90 percent / Et3N; DMAP / CH2Cl2 / 0 °C
4: 0.298 g / NaH; Pd(PPh3)4 / dimethylsulfoxide; tetrahydrofuran / 45 °C
5: ethanol / 5 h / Heating
6: aq. NaOH
View Scheme
Multi-step reaction with 5 steps
1: 97 percent / Grubbs catalyst / CH2Cl2
2: 78 percent / LiBH4 / tetrahydrofuran; methanol
3: 90 percent / Et3N, DMAP / CH2Cl2
4: 62 percent / NaH, Pd(PPh3)4 / tetrahydrofuran; dimethylsulfoxide
5: NaOH, H2O
View Scheme
Multi-step reaction with 6 steps
1: 97 percent / Grubbs catalyst / CH2Cl2
2: 78 percent / LiBH4 / tetrahydrofuran; methanol
3: 90 percent / Et3N, DMAP / CH2Cl2
4: 65 percent / NaH, Pd(PPh3)4 / tetrahydrofuran; dimethylsulfoxide
5: ethanol
6: NaOH, H2O
View Scheme
[4S,2R,3R]-(4-benzyl-2-thioxooxazolidin-3-yl)(2-hydroxycyclopent-3-enyl)methanone
268737-90-2

[4S,2R,3R]-(4-benzyl-2-thioxooxazolidin-3-yl)(2-hydroxycyclopent-3-enyl)methanone

abacavir
136470-78-5

abacavir

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: 85 percent / LiBH4 / tetrahydrofuran; methanol
2: 90 percent / Et3N; DMAP / CH2Cl2 / 0 °C
3: 62 percent / NaH; Pd(PPh3)4 / dimethylsulfoxide; tetrahydrofuran / 45 °C
4: aq. NaOH
View Scheme
Multi-step reaction with 5 steps
1: 85 percent / LiBH4 / tetrahydrofuran; methanol
2: 90 percent / Et3N; DMAP / CH2Cl2 / 0 °C
3: 0.298 g / NaH; Pd(PPh3)4 / dimethylsulfoxide; tetrahydrofuran / 45 °C
4: ethanol / 5 h / Heating
5: aq. NaOH
View Scheme
Multi-step reaction with 5 steps
1.1: 78 percent / LiBH4 / methanol
2.1: Et3N
3.1: Et3N; 4-DMAP
4.1: aq. HF / acetonitrile
5.1: Pd2(dba)3; PPh3; 1,2,2,6,6-pentamethylpiperidine (pempidine) / tetrahydrofuran; dimethylsulfoxide / 16 h / 45 °C
5.2: 60 percent / EtN(i-Pr)2 / butan-1-ol / 4 h / 80 °C
View Scheme
(E)-(2R,3R)-2-Allyl-hex-4-ene-1,3-diol
318488-34-5

(E)-(2R,3R)-2-Allyl-hex-4-ene-1,3-diol

abacavir
136470-78-5

abacavir

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: Et3N / CH2Cl2
2: (Cy3P)2Cl2Ru=CHPh / CH2Cl2 / 25 °C
3: 62 percent / NaH; Pd(PPh3)4 / dimethylsulfoxide; tetrahydrofuran / 45 °C
4: aq. NaOH
View Scheme
Multi-step reaction with 5 steps
1: Et3N / CH2Cl2
2: (Cy3P)2Cl2Ru=CHPh / CH2Cl2 / 25 °C
3: 0.298 g / NaH; Pd(PPh3)4 / dimethylsulfoxide; tetrahydrofuran / 45 °C
4: ethanol / 5 h / Heating
5: aq. NaOH
View Scheme
Acetic acid (1R,2R)-2-acetoxymethyl-1-((E)-propenyl)-pent-4-enyl ester

Acetic acid (1R,2R)-2-acetoxymethyl-1-((E)-propenyl)-pent-4-enyl ester

abacavir
136470-78-5

abacavir

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: (Cy3P)2Cl2Ru=CHPh / CH2Cl2 / 25 °C
2: 62 percent / NaH; Pd(PPh3)4 / dimethylsulfoxide; tetrahydrofuran / 45 °C
3: aq. NaOH
View Scheme
Multi-step reaction with 4 steps
1: (Cy3P)2Cl2Ru=CHPh / CH2Cl2 / 25 °C
2: 0.298 g / NaH; Pd(PPh3)4 / dimethylsulfoxide; tetrahydrofuran / 45 °C
3: ethanol / 5 h / Heating
4: aq. NaOH
View Scheme
(E)-(2S,3R)-2-Allyl-1-((S)-4-benzyl-2-thioxo-oxazolidin-3-yl)-3-hydroxy-hex-4-en-1-one
318488-32-3

(E)-(2S,3R)-2-Allyl-1-((S)-4-benzyl-2-thioxo-oxazolidin-3-yl)-3-hydroxy-hex-4-en-1-one

abacavir
136470-78-5

abacavir

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1: 77 percent / NaBH4 / tetrahydrofuran; H2O
2: Et3N / CH2Cl2
3: (Cy3P)2Cl2Ru=CHPh / CH2Cl2 / 25 °C
4: 62 percent / NaH; Pd(PPh3)4 / dimethylsulfoxide; tetrahydrofuran / 45 °C
5: aq. NaOH
View Scheme
Multi-step reaction with 6 steps
1: 77 percent / NaBH4 / tetrahydrofuran; H2O
2: Et3N / CH2Cl2
3: (Cy3P)2Cl2Ru=CHPh / CH2Cl2 / 25 °C
4: 0.298 g / NaH; Pd(PPh3)4 / dimethylsulfoxide; tetrahydrofuran / 45 °C
5: ethanol / 5 h / Heating
6: aq. NaOH
View Scheme
(E)-(2S,3R)-2-Allyl-1-((R)-4-benzyl-2-thioxo-oxazolidin-3-yl)-3-hydroxy-hex-4-en-1-one
318488-35-6

(E)-(2S,3R)-2-Allyl-1-((R)-4-benzyl-2-thioxo-oxazolidin-3-yl)-3-hydroxy-hex-4-en-1-one

abacavir
136470-78-5

abacavir

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1: 74 percent / (Cy3P)2Cl2Ru=CHPh / CH2Cl2 / 1 h / 40 °C
2: 85 percent / LiBH4 / tetrahydrofuran; methanol
3: 90 percent / Et3N; DMAP / CH2Cl2 / 0 °C
4: 62 percent / NaH; Pd(PPh3)4 / dimethylsulfoxide; tetrahydrofuran / 45 °C
5: aq. NaOH
View Scheme
Multi-step reaction with 6 steps
1: 74 percent / (Cy3P)2Cl2Ru=CHPh / CH2Cl2 / 1 h / 40 °C
2: 85 percent / LiBH4 / tetrahydrofuran; methanol
3: 90 percent / Et3N; DMAP / CH2Cl2 / 0 °C
4: 0.298 g / NaH; Pd(PPh3)4 / dimethylsulfoxide; tetrahydrofuran / 45 °C
5: ethanol / 5 h / Heating
6: aq. NaOH
View Scheme
(1R,5R)-5-(tert-Butyl-dimethyl-silanyloxymethyl)-cyclopent-2-enol
268737-91-3

(1R,5R)-5-(tert-Butyl-dimethyl-silanyloxymethyl)-cyclopent-2-enol

abacavir
136470-78-5

abacavir

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1.1: Et3N; 4-DMAP
2.1: aq. HF / acetonitrile
3.1: Pd2(dba)3; PPh3; 1,2,2,6,6-pentamethylpiperidine (pempidine) / tetrahydrofuran; dimethylsulfoxide / 16 h / 45 °C
3.2: 60 percent / EtN(i-Pr)2 / butan-1-ol / 4 h / 80 °C
View Scheme
Benzoic acid (1R,5R)-5-(tert-butyl-dimethyl-silanyloxymethyl)-cyclopent-2-enyl ester
268737-92-4

Benzoic acid (1R,5R)-5-(tert-butyl-dimethyl-silanyloxymethyl)-cyclopent-2-enyl ester

abacavir
136470-78-5

abacavir

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1.1: aq. HF / acetonitrile
2.1: Pd2(dba)3; PPh3; 1,2,2,6,6-pentamethylpiperidine (pempidine) / tetrahydrofuran; dimethylsulfoxide / 16 h / 45 °C
2.2: 60 percent / EtN(i-Pr)2 / butan-1-ol / 4 h / 80 °C
View Scheme
(2S,3R)-2-Allyl-1-((R)-4-benzyl-2-thioxo-oxazolidin-3-yl)-3-hydroxy-pent-4-en-1-one
268737-89-9

(2S,3R)-2-Allyl-1-((R)-4-benzyl-2-thioxo-oxazolidin-3-yl)-3-hydroxy-pent-4-en-1-one

abacavir
136470-78-5

abacavir

Conditions
ConditionsYield
Multi-step reaction with 6 steps
1.1: 97 percent / catalytic ring-closing metathesis (RCM)
2.1: 78 percent / LiBH4 / methanol
3.1: Et3N
4.1: Et3N; 4-DMAP
5.1: aq. HF / acetonitrile
6.1: Pd2(dba)3; PPh3; 1,2,2,6,6-pentamethylpiperidine (pempidine) / tetrahydrofuran; dimethylsulfoxide / 16 h / 45 °C
6.2: 60 percent / EtN(i-Pr)2 / butan-1-ol / 4 h / 80 °C
View Scheme
(-)-2-azabicyclo[2.2.1]hept-5-en-3-one
79200-56-9

(-)-2-azabicyclo[2.2.1]hept-5-en-3-one

abacavir
136470-78-5

abacavir

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: 1.264 g / tetrahydrofuran; H2O / 18 h / 20 - 60 °C
2: 90.5 percent / LiAlH4 / tetrahydrofuran / 19.5 h / 0 °C / Heating
3: 83 percent / Et3N / ethanol / 7 h / Heating
4: 60 percent / butan-1-ol / 21 h / 130 °C
View Scheme
Multi-step reaction with 5 steps
1: 1.264 g / tetrahydrofuran; H2O / 18 h / 20 - 60 °C
2: 90.5 percent / LiAlH4 / tetrahydrofuran / 19.5 h / 0 °C / Heating
3: 83 percent / Et3N / ethanol / 7 h / Heating
4: 92 percent / triethylorthoformate; HCl / H2O / 4 h
5: 90 percent / methanol / 12 h / 70 °C
View Scheme
abacavir
136470-78-5

abacavir

(1R,cis)-3-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]-1-cyclopentane-1-methanol

(1R,cis)-3-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]-1-cyclopentane-1-methanol

Conditions
ConditionsYield
With hydrogen; palladium on activated charcoal In ethanol under 2585.74 Torr; for 1.5h; Catalytic hydrogenation;98%
ethyl acetate
141-78-6

ethyl acetate

abacavir
136470-78-5

abacavir

((1S,4R)-4-(2-amino-6-(cyclopropylamino)-9H-purin-9-yl)cyclopent-2-en-1-yl)methyl acetate
178456-36-5

((1S,4R)-4-(2-amino-6-(cyclopropylamino)-9H-purin-9-yl)cyclopent-2-en-1-yl)methyl acetate

Conditions
ConditionsYield
With heterogeneous zinc/imidazole catalyst for 6.5h; Inert atmosphere; Schlenk technique; Reflux; chemoselective reaction;98%
abacavir
136470-78-5

abacavir

{(1S,4R)-4-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]cyclopent-2-en-1-yl}methanol sulphate

{(1S,4R)-4-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]cyclopent-2-en-1-yl}methanol sulphate

Conditions
ConditionsYield
With sulfuric acid In water; isopropyl alcohol at 50 - 55℃; for 2h; Concentration; Temperature; Solvent;95%
maleic acid
110-16-7

maleic acid

abacavir
136470-78-5

abacavir

(1S,4R)-4-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]-2-cyclopentene-1-methanol maleate
1280629-56-2

(1S,4R)-4-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]-2-cyclopentene-1-methanol maleate

Conditions
ConditionsYield
In ethanol at 25 - 30℃; for 0.25h;94.3%
4-dimethylamino-benzaldehyde
100-10-7

4-dimethylamino-benzaldehyde

abacavir
136470-78-5

abacavir

[(1S,4R)-4-(6-Cyclopropylamino-2-{[1-(4-dimethylamino-phenyl)-meth-(E)-ylidene]-amino}-purin-9-yl)-cyclopent-2-enyl]-methanol

[(1S,4R)-4-(6-Cyclopropylamino-2-{[1-(4-dimethylamino-phenyl)-meth-(E)-ylidene]-amino}-purin-9-yl)-cyclopent-2-enyl]-methanol

Conditions
ConditionsYield
With acetic acid microwave irradiation;89%
malonic acid
141-82-2

malonic acid

abacavir
136470-78-5

abacavir

(1S,4R)-4-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]-2-cyclopentene-1-methanol malonate
1280629-49-3

(1S,4R)-4-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]-2-cyclopentene-1-methanol malonate

Conditions
ConditionsYield
In ethanol at 25 - 70℃; for 0.75h; Product distribution / selectivity;88%
5-fluoro-1H-indole-2,3-dione
443-69-6

5-fluoro-1H-indole-2,3-dione

abacavir
136470-78-5

abacavir

3-[(E)-6-Cyclopropylamino-9-((1R,4S)-4-hydroxymethyl-cyclopent-2-enyl)-9H-purin-2-ylimino]-5-fluoro-1,3-dihydro-indol-2-one

3-[(E)-6-Cyclopropylamino-9-((1R,4S)-4-hydroxymethyl-cyclopent-2-enyl)-9H-purin-2-ylimino]-5-fluoro-1,3-dihydro-indol-2-one

Conditions
ConditionsYield
With acetic acid microwave irradiation;87%
2,2,2-trifluoroethyl benzoate
1579-72-2

2,2,2-trifluoroethyl benzoate

abacavir
136470-78-5

abacavir

((1S,4R)-4-(2-amino-6-(cyclopropylamino)-9H-purin-9-yl)cyclopent-2-en-1-yl)methyl benzoate

((1S,4R)-4-(2-amino-6-(cyclopropylamino)-9H-purin-9-yl)cyclopent-2-en-1-yl)methyl benzoate

Conditions
ConditionsYield
With (μ-oxo)bis[(1,2-ethanediamino-N,N'-bis(salicylidene))iron(III)] In toluene at 120℃; for 5h; Inert atmosphere; Schlenk technique; chemoselective reaction;87%
11-(acetylthio)undecanoic acid
6974-31-8

11-(acetylthio)undecanoic acid

abacavir
136470-78-5

abacavir

C27H40N6O3S

C27H40N6O3S

Conditions
ConditionsYield
With dmap; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In N,N-dimethyl-formamide at 0℃; for 5h;85%
1-ethenesulfonyl-piperidine
66089-45-0

1-ethenesulfonyl-piperidine

abacavir
136470-78-5

abacavir

N6-cyclopropyl-9-((1R,4S)-4-((2-(piperidin-1-ylsulfonyl)ethoxy)methyl)cyclopent-2-en-1-yl)-9H-purine-2,6-diamine

N6-cyclopropyl-9-((1R,4S)-4-((2-(piperidin-1-ylsulfonyl)ethoxy)methyl)cyclopent-2-en-1-yl)-9H-purine-2,6-diamine

Conditions
ConditionsYield
Stage #1: abacavir With silver(I) acetate; 1,2-bis-(diphenylphosphino)ethane In N,N-dimethyl-formamide at -20℃; Inert atmosphere;
Stage #2: 1-ethenesulfonyl-piperidine With potassium hexamethylsilazane In tetrahydrofuran; N,N-dimethyl-formamide at -20℃; for 21h; Inert atmosphere; regioselective reaction;
85%
abacavir
136470-78-5

abacavir

(1S,4R)-4-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]-2-cyclopentene-1-methanol dihydrobromide

(1S,4R)-4-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]-2-cyclopentene-1-methanol dihydrobromide

Conditions
ConditionsYield
With hydrogen bromide In ethanol; water at 25 - 30℃; for 0.75h; Product distribution / selectivity;83%
indole-2,3-dione
91-56-5

indole-2,3-dione

abacavir
136470-78-5

abacavir

3-[(E)-6-Cyclopropylamino-9-((1R,4S)-4-hydroxymethyl-cyclopent-2-enyl)-9H-purin-2-ylimino]-1,3-dihydro-indol-2-one

3-[(E)-6-Cyclopropylamino-9-((1R,4S)-4-hydroxymethyl-cyclopent-2-enyl)-9H-purin-2-ylimino]-1,3-dihydro-indol-2-one

Conditions
ConditionsYield
With acetic acid microwave irradiation;82%
abacavir
136470-78-5

abacavir

(1S,4R)-4-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]-2-cyclopentene-1-methanol hydrobromide
1280727-16-3

(1S,4R)-4-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]-2-cyclopentene-1-methanol hydrobromide

Conditions
ConditionsYield
With hydrogen bromide In ethanol; water at 25 - 30℃; for 0.75h; Product distribution / selectivity;82%
5-methyl-indole-2,3-dione
608-05-9

5-methyl-indole-2,3-dione

abacavir
136470-78-5

abacavir

3-[(E)-6-Cyclopropylamino-9-((1R,4S)-4-hydroxymethyl-cyclopent-2-enyl)-9H-purin-2-ylimino]-5-methyl-1,3-dihydro-indol-2-one

3-[(E)-6-Cyclopropylamino-9-((1R,4S)-4-hydroxymethyl-cyclopent-2-enyl)-9H-purin-2-ylimino]-5-methyl-1,3-dihydro-indol-2-one

Conditions
ConditionsYield
With acetic acid microwave irradiation;78%
C13H18ClN2O5P

C13H18ClN2O5P

abacavir
136470-78-5

abacavir

(S)-2-{[(1S,4R)-4-(2-Amino-6-cyclopropylamino-purin-9-yl)-cyclopent-2-enylmethoxy]-phenoxy-phosphorylamino}-propionic acid methyl ester
261909-26-6

(S)-2-{[(1S,4R)-4-(2-Amino-6-cyclopropylamino-purin-9-yl)-cyclopent-2-enylmethoxy]-phenoxy-phosphorylamino}-propionic acid methyl ester

Conditions
ConditionsYield
Stage #1: abacavir With tert-butylmagnesium chloride In tetrahydrofuran at -78℃; Inert atmosphere;
Stage #2: C13H18ClN2O5P In tetrahydrofuran at 20℃; Inert atmosphere;
76%
tert-butoxyacetic acid
13211-32-0

tert-butoxyacetic acid

abacavir
136470-78-5

abacavir

((1S,4R)-4-(2-amino-6-(cyclopropylamino)-9H-purin-9-yl)cyclopent-2-en-1-yl)methyl 2-(tert-butoxy)acetate

((1S,4R)-4-(2-amino-6-(cyclopropylamino)-9H-purin-9-yl)cyclopent-2-en-1-yl)methyl 2-(tert-butoxy)acetate

Conditions
ConditionsYield
With dmap; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane at 25 - 30℃;74%
tetra(n-butyl)ammonium hydroxide
2052-49-5

tetra(n-butyl)ammonium hydroxide

abacavir
136470-78-5

abacavir

C14H17N6O4P(2-)*2C16H36N(1+)

C14H17N6O4P(2-)*2C16H36N(1+)

Conditions
ConditionsYield
Stage #1: abacavir With pyridine; water; trichlorophosphate In acetonitrile at 0℃;
Stage #2: With water; ammonium bicarbonate In acetonitrile at 0℃; pH=8;
Stage #3: tetra(n-butyl)ammonium hydroxide In water; acetonitrile
72%
abacavir
136470-78-5

abacavir

4-Hydroxyacetophenone
99-93-4

4-Hydroxyacetophenone

4-{1-[(E)-6-Cyclopropylamino-9-((1R,4S)-4-hydroxymethyl-cyclopent-2-enyl)-9H-purin-2-ylimino]-ethyl}-phenol

4-{1-[(E)-6-Cyclopropylamino-9-((1R,4S)-4-hydroxymethyl-cyclopent-2-enyl)-9H-purin-2-ylimino]-ethyl}-phenol

Conditions
ConditionsYield
With acetic acid microwave irradiation;71%
tetra(n-butyl)ammonium hydroxide
2052-49-5

tetra(n-butyl)ammonium hydroxide

abacavir
136470-78-5

abacavir

abacavir monophosphate 1.15*nBu4N+ salt

abacavir monophosphate 1.15*nBu4N+ salt

Conditions
ConditionsYield
Stage #1: abacavir With trichlorophosphate at 0℃; for 1h; Inert atmosphere;
Stage #2: With water for 1h; Cooling with ice;
Stage #3: tetra(n-butyl)ammonium hydroxide In water pH=7.0;
71%
4-methoxy-benzaldehyde
123-11-5

4-methoxy-benzaldehyde

abacavir
136470-78-5

abacavir

[(1S,4R)-4-(6-Cyclopropylamino-2-{[1-(4-methoxy-phenyl)-meth-(E)-ylidene]-amino}-purin-9-yl)-cyclopent-2-enyl]-methanol

[(1S,4R)-4-(6-Cyclopropylamino-2-{[1-(4-methoxy-phenyl)-meth-(E)-ylidene]-amino}-purin-9-yl)-cyclopent-2-enyl]-methanol

Conditions
ConditionsYield
With acetic acid microwave irradiation;70%
1,10-decanedioic acid
111-20-6

1,10-decanedioic acid

abacavir
136470-78-5

abacavir

C38H50N12O4

C38H50N12O4

Conditions
ConditionsYield
Stage #1: 1,10-decanedioic acid With dmap; benzotriazol-1-yloxyl-tris-(pyrrolidino)-phosphonium hexafluorophosphate; diisopropylamine In N,N-dimethyl-formamide at -20℃; for 0.333333h;
Stage #2: abacavir In N,N-dimethyl-formamide at -20 - 20℃; for 16h;
70%

Abacavir Specification

1. Introduction of Abacavir
Abacavir is one kind of white powder. Its IUPAC name is called [(1S,4R)-4-[2-amino-6-(cyclopropylamino)purin-9-yl]cyclopent-2-en-1-yl]methanol. It belongs to classification codes which are Anti-HIV Agents, Anti-Infective Agents, Anti-Retroviral Agents, Antiviral Agents, Enzyme Inhibitors, Nucleic Acid Synthesis Inhibitors, Reverse Transcriptase Inhibitors. Besides, its Product Categories is Bases & Related Reagents;Inhibitors;Intermediates & Fine Chemicals;Nucleotides;Pharmaceuticals. It should be store at refrigerator. Abacavir can be soluble in water. Its Classification Codes is Anti-HIV Agents; Anti-Infective Agents; Anti-Retroviral Agents; Antiviral Agents; Enzyme Inhibitors; Nucleic Acid Synthesis Inhibitors; Reverse Transcriptase Inhibitors.

2. Properties of Abacavir
Physical properties about Abacavir are:
(1) ACD/LogP: -0.78 ; (2) # of Rule of 5 Violations: 0 ; (3) ACD/LogD (pH 7.4): 0.66 ; (4) ACD/BCF (pH 5.5): 1 ; (5) ACD/BCF (pH 7.4): 1.8 ; (6) ACD/KOC (pH 5.5): 4.47 ; (7) ACD/KOC (pH 7.4): 50.77 ; (8) #H bond acceptors: 7 ; (9) #H bond donors: 4 ; (10) #Freely Rotating Bonds: 4 ; (11) Polar Surface Area: 59.31 Å2 ; (12) Index of Refraction: 1.864 ; (13) Molar Refractivity: 75.8 cm3 ; (14) Molar Volume: 167.6 cm3 ; (15) Surface Tension: 80.1 dyne/cm ; (16) Density: 1.7 g/cm3 ; (17) Flash Point: 338.4 °C ; (18) Enthalpy of Vaporization: 98.77 kJ/mol ; (19) Boiling Point: 636 °C at 760 mmHg ; (20) Vapour Pressure: 4.77E-17 mmHg at 25°C.

3. Structure Descriptors of Abacavir
(1) SMILES:n3c1c(ncn1[C@H]2/C=C\[C@@H](CO)C2)c(nc3N)NC4CC4;
(2) InChI:InChI=1/C14H18N6O/c15-14-18-12(17-9-2-3-9)11-13(19-14)20(7-16-11)10-4-1-8(5-10)6-21/h1,4,7-10,21H,2-3,5-6H2,(H3,15,17,18,19)/t8-,10+/m1/s1;
(3) InChIKey:MCGSCOLBFJQGHM-SCZZXKLOBP

4. Uses of Abacavir
Abacavir (ABC) is a powerful nucleoside analog reverse transcriptase inhibitor (NRTI) used to treat HIV and AIDS. This compound has been used as a drug with the trade name of Ziagen. It is a kind of antiretroviral drugs approved by the Food and Drug Administration (FDA). It has tablets and oral solution. This drug is used to treat HIV and AIDS in combination with other antiretroviral agents. It can be used for research and manufacture Epzicom tablet.

5. Production of Abacavir
030-8 1.0g (0.0053mol), in the reaction flask was added cesium carbonate 1.75 g (0.0054 mol) and dry DMSO 50ml, stirred under N2 protection, the temperature was raised to 60 °C and stirred at this temperature for 2 h the mixture wascooled to room temperature, then add tetrakis (triphenylphosphine) combined palladium (TTP) [0.85 (0.00074mol)] and compound 030-5 [0.79g (0.0034 mol), DMSO (10 ml) solution was stirred and heated to 65 °C held 65 °C and stirred reaction 2.25h. The you can get the mixture containing compounds 030-9.

To the mixture was added methanol 100ml and K2CO3 is 2.10g, the mixture reaction was stirred for 45min at 40 °C, a solid precipitate which was filtered through a Celite layer and the filtrate was evaporated to a small volume under vacuum at 90 °C, and the remaining gum pounding mill was extracted with dichloromethane (100ml * 2) to give a brown solid residue was purified by silica gel (Merck 9385) column chromatography [eluent: dichloromethane / methanol (volume ratio 9:1)] to give a yellow foam was 030 0.26 g, yield 26.8.

Production of Abacavir

Post buying leads

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View